欧盟EMA药品数据库-欧盟集中审批药品（European Medicines Agency Authorisation of Medicines DataBase）

商品名称	适用类别	通用名称	活性成分	产品号	上市许可开发者/申请人/持有人	上市许可日期	许可状态
Gavreto	Human	pralsetinib	pralsetinib	EMEA/H/C/005413	Blueprint Medicines (Netherlands) B.V.	2021/11/18	Withdrawn
Hukyndra	Human	adalimumab	adalimumab	EMEA/H/C/005548	Stada Arzneimittel AG	2021/11/15	Authorised
Sugammadex Mylan	Human	sugammadex	sugammadex sodium	EMEA/H/C/005403	Mylan Pharmaceuticals Limited	2021/11/15	Authorised
Vumerity	Human	diroximel fumarate	Diroximel fumarate (BIIB098)	EMEA/H/C/005437	Biogen Netherlands B.V.	2021/11/15	Authorised
Libmyris	Human	adalimumab	adalimumab	EMEA/H/C/005947	Stada Arzneimittel AG	2021/11/12	Authorised
Rivaroxaban Viatris (previously Rivaroxaban Mylan)	Human	rivaroxaban	rivaroxaban	EMEA/H/C/005600	Viatris Limited	2021/11/12	Authorised
Regkirona	Human	regdanvimab	regdanvimab	EMEA/H/C/005854	Celltrion Healthcare Hungary Kft.	2021/11/12	Withdrawn
Ronapreve	Human	casirivimab;imdevimab	casirivimab;imdevimab	EMEA/H/C/005814	Roche Registration GmbH	2021/11/12	Authorised
Imatinib Koanaa	Human	imatinib	imatinib mesilate	EMEA/H/C/005595	Koanaa Healthcare GmbH	2021/09/22	Withdrawn
Ozawade	Human	pitolisant	pitolisant	EMEA/H/C/005117	Bioprojet Pharma	2021/09/01	Authorised
Minjuvi	Human	tafasitamab	tafasitamab	EMEA/H/C/005436	Incyte Biosciences Distribution B.V.	2021/08/26	Authorised
Voxzogo	Human	vosoritide	vosoritide	EMEA/H/C/005475	BioMarin International Limited	2021/08/26	Authorised
Bimzelx	Human	bimekizumab	bimekizumab	EMEA/H/C/005316	UCB Pharma S.A.	2021/08/20	Authorised
Abiraterone Mylan	Human	abiraterone acetate	abiraterone acetate	EMEA/H/C/005368	Mylan Pharmaceuticals Limited	2021/08/20	Authorised
Abecma	Human	idecabtagene vicleucel	idecabtagene vicleucel	EMEA/H/C/004662	Bristol-Myers Squibb Pharma EEIG	2021/08/18	Authorised
Fingolimod Mylan	Human	fingolimod		EMEA/H/C/005661	Mylan Pharmaceuticals Limited	2021/08/18	Authorised
Evrenzo	Human	roxadustat	roxadustat	EMEA/H/C/004871	Astellas Pharma Europe B.V.	2021/08/18	Authorised
Byooviz	Human	ranibizumab	ranibizumab	EMEA/H/C/005545	Samsung Bioepis NL B.V.	2021/08/18	Authorised
Fingolimod Mylan	Human	fingolimod	fingolimod hydrochloride	EMEA/H/C/005282	Mylan Ireland Limited	2021/08/18	Application withdrawn
Verquvo	Human	vericiguat	vericiguat	EMEA/H/C/005319	Bayer AG	2021/07/16	Authorised

商品名称Name of medicine	*示例：Zokinvy（英文）
药品通用名或非专利名称International non-proprietary name (INN) / common name	*示例：lonafarnib（英文）
活性成分Active substance	*示例：lonafarnib（英文）
产品号EMA product number	*示例：EMEA/H/C/005271
ATC编号ATC code	*示例：L01EA06
上市许可开发者/申请人/持有人Marketing authorisation developer / applicant / holder	*示例：Janssen
药物治疗学分组Pharmacotherapeutic group	*示例：Antineoplastic
适应症Therapeutic indication	*示例：leukaemia
许可状态Medicine status
上市许可日期Marketing authorisation date	-